STAAR Surgical Co SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
STAAR Surgical Co (STAA) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $24.71 million for the 12-month period ending 2026-01-02, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Valuation and Qualifying Accounts
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2026-03-03
- STAAR Surgical Co sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2026 was $24.71M, a 11.23% increase from fiscal 2024.
- STAAR Surgical Co sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2024 was $22.22M, a 14.20% increase from fiscal 2023.
- STAAR Surgical Co sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2023 was $19.46M, a 16.85% increase from fiscal 2022.
- STAAR Surgical Co sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2022 was $16.65M.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month as first filed |
|---|---|---|
| 2026-01-02 | $24.71M 10-K · filed 2026-03-03 | |
| 2024-12-27 | $22.22M 10-K · filed 2026-03-03 | |
| 2023-12-29 | $19.46M 10-K · filed 2026-03-03 | |
| 2022-12-31 | $16.65M 10-K · filed 2023-02-23 | |
| 2022-12-30 | $14.60M 10-K · filed 2025-02-21 | |
| 2021-12-31 | $10.80M 10-K · filed 2024-02-27 | $23.75M 10-K · filed 2022-02-23 |
| 2021-01-01 | $15.17M 10-K · filed 2023-02-23 | $11.94M 10-K · filed 2021-02-24 |
| 2020-01-03 | $1.07M 10-K · filed 2022-02-23 | $604.00K 10-K · filed 2020-02-26 |
| 2018-12-28 | $8.21M 10-K · filed 2021-02-24 | |
| 2017-12-29 | $6.65M 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |